FDA OK’s first drug for morning sickness in more than 50 years

By Toni Clarke WASHINGTON (Reuters) – U.S. health regulators have approved a drug to treat morning sickness that was withdrawn from the market 30 years ago amid claims, since debunked, that it caused birth defects. The drug, Diclegis, made by Duchesnay Inc, a private Canadian company, is a generic version of a product that was initially approved in the United States under the name Bendectin in 1956. It was withdrawn in 1983 following a slew of lawsuits from mothers claiming their children had been harmed by it. The U.S. …